GUNA-LIVER
- Manufacturer
- Guna spa
- Effective date
- 2018-12-21
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:11:02
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Carduus marianus 2X DETOXIFICATION
Ceanothus americanus 6X DETOXIFICATION
Chelidonium majus 2X DETOXIFICATION
Chionanthus virginica 6X PAIN RELIEVER
Cholinum 4X STIMULATES DIGESTION
Cobalamin 4X ANTIOXIDANT
Fumaricum acidum 4X ANTIOXIDANT
Gall bladder 8X STIMULATES DIGESTION
Hepar 6X STIMULATES DIGESTION
Inositol 4X STIMULATES DIGESTION
Jejunum 8X STIMULATES DIGESTION
Kali sulphuricum 6X 8X 12X STOMACH ACTIVITY
Leptandra virginica 6X STIMULATES DIGESTION
Lycopodium clavatum 6X LAXATIVE
Natrum oxalaceticum 4X ANTIOXIDANT
Natrum pyruvicum 4X ANTIOXIDANT
Natrum sulphuricum 6X 8X 12X STOMACH ACTIVITY
Niacin 6X METABOLIC SUPPORT
Pancreas 8X STIMULATES DIGESTION
Pyridoxinum hydrochloricum 6X ANTIOXIDANT
Riboflavinum 6X ANTIOXIDANT
Spleen 8X DETOXIFICATION
Taraxacum officinale 2X LAXATIVE
Thiaminum hydrochloricum 6X ANTIOXIDANT
OTC - PURPOSE SECTION
Temporary relief of symptoms of colic and gas pains such as:
- Bloating
- General aches and pains
WARNINGS SECTION
Stop use and ask doctor if symptoms persist more than 5 days or worsen.
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children
DOSAGE & ADMINISTRATION SECTION
Adults and children 12 years and older 5 pellets 3 times per day
Children between 12 years and 6 years of age 3 pellets 3 times per day
Children under 6 years 1 pellet 3 times per day to be dissolved into a little water
OTC - QUESTIONS SECTION
Questions?: info@gunainc.com
tel. (484) 223-3500
INDICATIONS & USAGE SECTION
Turn tube upside down and rotate cap to release pellets into cap.
Unscrew cap and without touching pellets tip them into the mouth under the tongue.
Allow to dissolve
Take 15 minutes before meals.
INACTIVE INGREDIENT SECTION
Inactive ingredient: Sucrose.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17089-311-20 | GUNA-LIVER | 2 in 1 BOX | PELLET | 2 | 2 | |
| 17089-311-20 | GUNA-LIVER | 4 g in 1 TUBE | PELLET | 4 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17089-311 | GUNA-LIVER (CEANOTHUS AMERICANUS LEAF - CHELIDONIUM MAJUS - CHIONANTHUS VIRGINICUS BARK - CHOLINE HYDROXIDE - COBALAMIN - CULVER ROOT - FUMARIC ACID - INOSITOL - LYCOPODIUM CLAVATUM SPORE - NIACIN - PORK LIVER - POTASSIUM SULFATE - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SILYBUM MARIANUM SEED - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SODIUM SULFATE - SUS SCROFA GALL BLADDER - SUS SCROFA JEJUNUM - SUS SCROFA PANCREAS - SUS SCROFA SPLEEN - TARAXACUM OFFICINALE - THIAMINE HYDROCHLORIDE -) PELLET [GUNA SPA] | 2 | Current NDC, Legacy NDC, 2 package rows | 20190306_ab42235e-6080-492c-b5f2-fdbeb663a24d.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CEANOTHUS AMERICANUS LEAF | ACTIVE INGREDIENT | 25B1Y14T8N | 1 | |
| CHELIDONIUM MAJUS | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| CHIONANTHUS VIRGINICUS BARK | ACTIVE INGREDIENT | S9Y4B22U2E | 1 | |
| CHOLINE HYDROXIDE | ACTIVE INGREDIENT | 7THJ3EG9SY | 1 | |
| COBALAMIN | ACTIVE INGREDIENT | 8406EY2OQA | 1 | |
| CULVER'S ROOT | ACTIVE INGREDIENT | M2O62YTN42 | 1 | |
| FUMARIC ACID | ACTIVE INGREDIENT | 88XHZ13131 | 1 | |
| INOSITOL | ACTIVE INGREDIENT | 4L6452S749 | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| NIACIN | ACTIVE INGREDIENT | 2679MF687A | 1 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| POTASSIUM SULFATE | ACTIVE INGREDIENT | 1K573LC5TV | 1 | |
| PYRIDOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| RIBOFLAVIN | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| SILYBUM MARIANUM SEED | ACTIVE INGREDIENT | U946SH95EE | 1 | |
| SODIUM DIETHYL OXALACETATE | ACTIVE INGREDIENT | 6CA025Y4FG | 1 | |
| SODIUM PYRUVATE | ACTIVE INGREDIENT | POD38AIF08 | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| SUS SCROFA GALL BLADDER | ACTIVE INGREDIENT | B6A98VOI9I | 1 | |
| SUS SCROFA JEJUNUM | ACTIVE INGREDIENT | TA501QD69R | 1 | |
| SUS SCROFA PANCREAS | ACTIVE INGREDIENT | 9Y3J3362RY | 1 | |
| SUS SCROFA SPLEEN | ACTIVE INGREDIENT | 92AMN5J79Y | 1 | |
| TARAXACUM OFFICINALE | ACTIVE INGREDIENT | 39981FM375 | 1 | |
| THIAMINE HYDROCHLORIDE | ACTIVE INGREDIENT | M572600E5P | 1 | |
| CEANOTHUS AMERICANUS LEAF | ACTIVE MOIETY | 25B1Y14T8N | 1 | |
| CHELIDONIUM MAJUS | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| CHIONANTHUS VIRGINICUS BARK | ACTIVE MOIETY | S9Y4B22U2E | 1 | |
| CHOLINE HYDROXIDE | ACTIVE MOIETY | 7THJ3EG9SY | 1 | |
| COBALAMIN | ACTIVE MOIETY | 8406EY2OQA | 1 | |
| CULVER'S ROOT | ACTIVE MOIETY | M2O62YTN42 | 1 | |
| DIETHYL OXALACETATE | ACTIVE MOIETY | 15S56468G7 | 1 | |
| FUMARIC ACID | ACTIVE MOIETY | 88XHZ13131 | 1 | |
| INOSITOL | ACTIVE MOIETY | 4L6452S749 | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 1 | |
| NIACIN | ACTIVE MOIETY | 2679MF687A | 1 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| PYRUVIC ACID | ACTIVE MOIETY | 8558G7RUTR | 1 | |
| RIBOFLAVIN | ACTIVE MOIETY | TLM2976OFR | 1 | |
| SILYBUM MARIANUM SEED | ACTIVE MOIETY | U946SH95EE | 1 | |
| SULFATE ION | ACTIVE MOIETY | 7IS9N8KPMG | 1 | |
| SUS SCROFA GALL BLADDER | ACTIVE MOIETY | B6A98VOI9I | 1 | |
| SUS SCROFA JEJUNUM | ACTIVE MOIETY | TA501QD69R | 1 | |
| SUS SCROFA PANCREAS | ACTIVE MOIETY | 9Y3J3362RY | 1 | |
| SUS SCROFA SPLEEN | ACTIVE MOIETY | 92AMN5J79Y | 1 | |
| TARAXACUM OFFICINALE | ACTIVE MOIETY | 39981FM375 | 1 | |
| THIAMINE | ACTIVE MOIETY | X66NSO3N35 | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- GUNA-LIVER
- CEANOTHUS AMERICANUS LEAF - CHELIDONIUM MAJUS - CHIONANTHUS VIRGINICUS BARK - CHOLINE HYDROXIDE - COBALAMIN - CULVER ROOT - FUMARIC ACID - INOSITOL - LYCOPODIUM CLAVATUM SPORE - NIACIN - PORK LIVER - POTASSIUM SULFATE - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SILYBUM MARIANUM SEED - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SODIUM SULFATE - SUS SCROFA GALL BLADDER - SUS SCROFA JEJUNUM - SUS SCROFA PANCREAS - SUS SCROFA SPLEEN - TARAXACUM OFFICINALE - THIAMINE HYDROCHLORIDE -
- SUCROSE
- SILYBUM MARIANUM SEED
- CEANOTHUS AMERICANUS LEAF
- CHELIDONIUM MAJUS
- CHIONANTHUS VIRGINICUS BARK
- CHOLINE HYDROXIDE
- CHOLINE
- COBALAMIN
- FUMARIC ACID
- SUS SCROFA GALLBLADDER
- PORK LIVER
- INOSITOL
- SUS SCROFA JEJUNUM
- POTASSIUM SULFATE
- POTASSIUM CATION
- SULFATE ION
- CULVER'S ROOT
- LYCOPODIUM CLAVATUM SPORE
- SODIUM DIETHYL OXALACETATE
- DIETHYL OXALACETATE
- SODIUM PYRUVATE
- PYRUVIC ACID
- SODIUM SULFATE
- SODIUM CATION
- NIACIN
- SUS SCROFA PANCREAS
- PYRIDOXINE HYDROCHLORIDE
- PYRIDOXINE
- RIBOFLAVIN
- SUS SCROFA SPLEEN
- TARAXACUM OFFICINALE
- THIAMINE HYDROCHLORIDE
- THIAMINE ION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17089-311 | 17089-311-20 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GUNA-LIVER | CEANOTHUS AMERICANUS LEAF - CHELIDONIUM MAJUS - CHIONANTHUS VIRGINICUS BARK - CHOLINE HYDROXIDE - COBALAMIN - CULVER ROOT - FUMARIC ACID - INOSITOL - LYCOPODIUM CLAVATUM SPORE - NIACIN - PORK LIVER - POTASSIUM SULFATE - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SILYBUM MARIANUM SEED - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SODIUM SULFATE - SUS SCROFA GALL BLADDER - SUS SCROFA JEJUNUM - SUS SCROFA PANCREAS - SUS SCROFA SPLEEN - TARAXACUM OFFICINALE - THIAMINE HYDROCHLORIDE - | Guna spa | ab42235e-6080-492c-b5f2-fdbeb663a24d | 2018-12-21 | Warnings | 17089-311-20 17089-311 17089031120 7df3b26c-3724-e74d-e053-2991aa0a8046 ab42235e-6080-492c-b5f2-fdbeb663a24d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
